ENAH and neoplasm: Mena has been used in the development of a prognostic marker of hematogenous metastasis called TMEM (Tumor Micro-Environment for Metastasis), shown to be associated with risk of metastasis in breast cancer patients independently of traditional prognostic markers [12].